RASSF1 and neoplasm: The expression level of RASSF1A was significantly lower in tumor samples at all stages than that in normal samples, and the promoter methylation level of RASSF1A seemed negatively correlated with its expression in tumor samples at Stage I, but there was no significant difference (Spearman correlation, P > 0.05) (Figure 4E).